* Since the publication of the 2016 report, an additional federal, non-qui-tam settlement with Syncor, in 2002 for $2.5 million ($0.5 million civil penalty; $2 million criminal penalty) for kickbacks, was found and added to the database.
** Settlements that involved more than one type of violation were reviewed and, where possible, individual penalties for each type of violation were determined and added to the totals for that violation. The final total for 鈥渕ultiple violations鈥 represents the sum total that could not be (or was not) attributed to a single violation.
Citation formats
Pharmaceutical industry financial penalties in the U.S. 1991-2017, by violation type
This statistic represents the amount of money the pharmaceutical industry in the U.S. had to pay in financial penalties from 1991 to 2017, by type of violation. Over this time the pharmaceutical industry paid some *** billion U.S. dollars in financial penalties due to poor manufacturing practices in which they sold drug products that failed to meet FDA standards or specifications.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how 糖心破解版 can support your business.
Public Citizen. (March 14, 2018). Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars) [Graph]. In 糖心破解版. Retrieved July 27, 2026, from /statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
Public Citizen. "Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars)." Chart. March 14, 2018. 糖心破解版. Accessed July 27, 2026. /statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
Public Citizen. (2018). Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars). 糖心破解版. 糖心破解版 Inc.. Accessed: July 27, 2026. /statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
Public Citizen. "Pharmaceutical Industry Financial Penalties in The U.S. from 1991 to 2017, by Type of Violation (in Million U.S. Dollars)." 糖心破解版, 糖心破解版 Inc., 14 Mar 2018, /statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
Public Citizen, Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars) 糖心破解版, /statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/ (last visited July 27, 2026)
Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars) [Graph], Public Citizen, March 14, 2018. [Online]. Available: /statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
